top of page

Post-Budget Summit

The half-day summit will discuss the implications of the Labor federal government's first Budget and the progress of other policy initiatives, including the National Medicines Policy and health technology assessment reviews.

Sydney, Australia
31 October 2022

BPD Annual Conference 2023

'An opportunity for a wider discussion'

The annual event will take place after the 2023-24 Budget. The premier annual conference of the pharmaceutical industry is widening its focus to reflect the alignment of interests across the biopharmaceutical, medical device and diagnostic sectors.

15 May 2022
15 May 2023
Sydney, Australia
Sydney, Australia
'ivy ballroom'

About The Event.

The annual conference of the BioPharmaDispatch publisher, Daily Dispatch, provides a full-day opportunity to discuss the federal government's 2023-24 Budget and other related issues.

Wider consideration of the issues.

The biopharmaceutical, medical device and diagnostic sectors share many of the same issues and challenges. Is there an opportunity for greater collaboration and cross-sector alignment on policy and stakeholder engagement? Is it even possible?


The conference program will be built to provide an engaging, informed and wide-ranging discussion on these and other related issues with the goal to ensure an open dialogue involving patients.

Complimentary registration will be available for patients and their representatives - email for more information.






Conference Program.



Venue opens

8.45 - 9.00am

Official open


Mark Butler MP

Minister for Health and Aged Care


9.00am - 9.30am

Address with Q&A - The Coalition's response to the 2023-24 Budget and its priorities


Senator The Hon. Anne Ruston

Shadow Minister for Health and Aged Care

Shadow Minister for Sport'

9.30am - 10.00am

Panel - The 'good, the not so good, and the opportunities

Adam Roach, Vice President, Head of Asia Pacific, BeiGene

Jaime McCoy, General Manager ANZ, Gilead Sciences

Richard Vines, Founder and CEO, Rare Cancers Australia

10.00am - 10.30am

One-on-one discussion - The campaign against 'double-dispensing'

Professor Trent Twomey, National President, Pharmacy Guild of Australia

10.30am - 11.00am


11.00am - 11.45am

Panel - A shared experience

Kate Holliday, CEO, Centre for Community-Driven Research

Felicity McNeill PSM, Founder and Chair, Better Access Australia

11.45am - 12.40pm

One-on-one discussion - Reflections

Professor Andrew Wilson, Chair, Pharmaceutical Benefits Advisory Committee

12.40pm - 1.30pm


1.30pm - 2.10pm

One-on-one discussion - A New Zealand patient perspective

Dr Malcolm Mulholland, Chair, Patient Voice Aotearoa

2.10pm - 3.00pm

Panel - An Australian patient perspective

Ruth Colagiuri AM, Founder and Director, Juvenile Arthritis Foundation Australia

Giulia Jones, CEO, Painaustralia

3.00pm - 3.30pm


3.30pm - 4.15pm

Panel - Lessons from medical devices and diagnostics

Pat Williams, Vice President ANZ, Edwards Lifesciences

Andrea Kunca, Market Access and Public Policy Lead, Roche Diagnostics Australia

4.15pm - 5.00pm

Panel - Where to from here

Liz de Somer, CEO, Medicines Australia

Ian Burgess, CEO, Medical Technology Association of Australia

5.00pm - 6.00pm




Register for the BPD Annual Conference 2023

bottom of page